Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| LEONARDI JACOPO | EVP and President, Immunology | 28 | $0 | $0 | 2016-06-03 |
| MCCOY JOHN A. | SVP and Controller | 25 | $0 | $0 | 2016-06-03 |
| ZAGAME PATRICE | See Remarks | 7 | $0 | $0 | 2016-06-03 |
| GLASSPOOL JOHN | See Remarks | 24 | $0 | $0 | 2016-06-03 |
| ORLOFF JOHN J | See Remarks | 10 | $0 | $0 | 2016-06-03 |
| ROSA-BJORKESON DAGMAR | See Remarks | 11 | $0 | $0 | 2016-06-03 |
| Ferrante Karen Jean | Director | 5 | $0 | $0 | 2016-06-03 |
| Edwards Peter G | SVP and General Counsel | 5 | $0 | $0 | 2016-06-03 |
| Meek David D. | EVP and President, Oncology | 13 | $0 | $0 | 2016-06-03 |
| Goff Brian | EVP and President, Hematology | 25 | $0 | $0 | 2016-06-03 |
| HOMBACH ROBERT J. | EVP. CFO and COO | 25 | $0 | $0 | 2016-06-03 |
| HANTSON LUDWIG | President and CEO | 25 | $0 | $0 | 2016-06-03 |
| LAW ANNE-MARIE | EVP & Head of Human Resources | 11 | $0 | $0 | 2016-06-03 |
| Nader Francois | Director | 5 | $0 | $0 | 2016-06-03 |
| Devitt Blake E | Director | 26 | $231.1K | $0 | 2016-06-03 |
| FORSYTH JOHN D | Director | 26 | $0 | $226.2K | 2016-06-03 |
| GAVIN JAMES R III | Director | 28 | $0 | $226.2K | 2016-06-03 |
| HOCKMEYER WAYNE T | Director | 24 | $0 | $0 | 2016-06-03 |
| STROUCKEN ALBERT P L | Director | 28 | $0 | $226.3K | 2016-06-03 |
| FOSLER GAIL D | Director | 20 | $0 | $0 | 2016-06-03 |
| BAXTER INTERNATIONAL INC | 10% Owner | 4 | $0 | $0 | 2016-03-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,280 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 12,588 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 293 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,320 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,680 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,960 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 1,887 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 11,137 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 63,406 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 8,327 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 9,292 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer deriv | 2016-06-03 | 2016-06-07 | 25,459 | — | $0 | 0 | SEC↗ |
| Nader Francois | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,960 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,680 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,320 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,810 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,499 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,280 | — | $0 | 0 | SEC↗ |
| ZAGAME PATRICE | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 108,336 | — | $0 | 0 | SEC↗ |
| ZAGAME PATRICE | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,168 | — | $0 | 0 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | D To issuer deriv | 2016-06-03 | 2016-06-07 | 75,835 | — | $0 | 0 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | D To issuer deriv | 2016-06-03 | 2016-06-07 | 23,447 | — | $0 | 0 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | D To issuer deriv | 2016-06-03 | 2016-06-07 | 77,146 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 293 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 12,588 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,320 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 2,500 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,680 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 103,181 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 287,936 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 328,253 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 507,380 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 84,367 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,597 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 118,953 | — | $0 | 0 | SEC↗ |
| Meek David D. | EVP and President, Oncology | D To issuer deriv | 2016-06-03 | 2016-06-07 | 191,421 | — | $0 | 0 | SEC↗ |
| Meek David D. | EVP and President, Oncology | D To issuer deriv | 2016-06-03 | 2016-06-07 | 43,334 | — | $0 | 0 | SEC↗ |
| Meek David D. | EVP and President, Oncology | D To issuer deriv | 2016-06-03 | 2016-06-07 | 54,553 | — | $0 | 0 | SEC↗ |
| Meek David D. | EVP and President, Oncology | D To issuer deriv | 2016-06-03 | 2016-06-07 | 6,155 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,320 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,680 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,280 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,810 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| ORLOFF JOHN J | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 21,667 | — | $0 | 0 | SEC↗ |
| ORLOFF JOHN J | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 82,063 | — | $0 | 0 | SEC↗ |
| ORLOFF JOHN J | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,168 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,280 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 12,588 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 293 | — | $0 | 0 | SEC↗ |
| Edwards Peter G | SVP and General Counsel | D To issuer deriv | 2016-06-03 | 2016-06-07 | 76,202 | — | $0 | 0 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | D To issuer deriv | 2016-06-03 | 2016-06-07 | 54,553 | — | $0 | 0 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | D To issuer deriv | 2016-06-03 | 2016-06-07 | 86,669 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,320 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,110 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,930 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,020 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,990 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,680 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,760 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 4,280 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer deriv | 2016-06-03 | 2016-06-07 | 3,810 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 2,051 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 43,376 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 230,627 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 39,674 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 11,263 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 8,327 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 23,447 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 55,104 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 10,000 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 14,274 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer deriv | 2016-06-03 | 2016-06-07 | 15,929 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 103,181 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 49,628 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,597 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 95,163 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 380,535 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 35,170 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer deriv | 2016-06-03 | 2016-06-07 | 287,936 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 265,221 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 35,170 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,168 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 31,376 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 25,773 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer deriv | 2016-06-03 | 2016-06-07 | 37,000 | — | $0 | 0 | SEC↗ |
| Devitt Blake E | Director | D To issuer | 2016-06-03 | 2016-06-07 | 32,857 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer | 2016-06-03 | 2016-06-07 | 7,657 | — | $0 | 0 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2016-06-03 | 2016-06-07 | 854 | — | $0 | 24,909 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | D To issuer | 2016-06-03 | 2016-06-07 | 24,909 | — | $0 | 0 | SEC↗ |
| Nader Francois | Director | D To issuer | 2016-06-03 | 2016-06-07 | 7,657 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | D To issuer | 2016-06-03 | 2016-06-07 | 30,747 | — | $0 | 0 | SEC↗ |
| ZAGAME PATRICE | See Remarks | D To issuer | 2016-06-03 | 2016-06-07 | 88,942 | — | $0 | 0 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | D To issuer | 2016-06-03 | 2016-06-07 | 85,262 | — | $0 | 0 | SEC↗ |
| HOCKMEYER WAYNE T | Director | D To issuer | 2016-06-03 | 2016-06-07 | 19,039 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | D To issuer | 2016-06-03 | 2016-06-07 | 435,102 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award | 2016-06-03 | 2016-06-07 | 16,356 | — | $0 | 435,102 | SEC↗ |
| Meek David D. | EVP and President, Oncology | D To issuer | 2016-06-03 | 2016-06-07 | 51,640 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | D To issuer | 2016-06-03 | 2016-06-07 | 27,827 | — | $0 | 0 | SEC↗ |
| ORLOFF JOHN J | See Remarks | D To issuer | 2016-06-03 | 2016-06-07 | 96,384 | — | $0 | 0 | SEC↗ |
| FOSLER GAIL D | Director | D To issuer | 2016-06-03 | 2016-06-07 | 39,364 | — | $0 | 0 | SEC↗ |
| Edwards Peter G | SVP and General Counsel | D To issuer | 2016-06-03 | 2016-06-07 | 216,343 | — | $0 | 0 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | D To issuer | 2016-06-03 | 2016-06-07 | 71,293 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer | 2016-06-03 | 2016-06-07 | 22,194 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | D To issuer | 2016-06-03 | 2016-06-07 | 696 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer | 2016-06-03 | 2016-06-07 | 1,095 | — | $0 | 0 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2016-06-03 | 2016-06-07 | 1,033 | — | $0 | 56,364 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | D To issuer | 2016-06-03 | 2016-06-07 | 56,364 | — | $0 | 0 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2016-06-03 | 2016-06-07 | 1,461 | — | $0 | 41,099 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | D To issuer | 2016-06-03 | 2016-06-07 | 41,099 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | D To issuer | 2016-06-03 | 2016-06-07 | 209,089 | — | $0 | 0 | SEC↗ |
| HOMBACH ROBERT J. | EVP. CFO and COO | A Award | 2016-06-03 | 2016-06-07 | 16,356 | — | $0 | 209,089 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | D To issuer | 2016-06-03 | 2016-06-07 | 70,047 | — | $0 | 0 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2016-06-03 | 2016-06-07 | 2,881 | — | $0 | 70,047 | SEC↗ |
| Devitt Blake E | Director | P Buy | 2016-05-24 | 2016-05-26 | 387 | — | $0 | 32,857 | SEC↗ |
| STROUCKEN ALBERT P L | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 22,194 | SEC↗ |
| Devitt Blake E | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 32,470 | SEC↗ |
| GAVIN JAMES R III | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 30,747 | SEC↗ |
| FORSYTH JOHN D | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 27,827 | SEC↗ |
| Nader Francois | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 7,657 | SEC↗ |
| HOCKMEYER WAYNE T | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 19,039 | SEC↗ |
| Ferrante Karen Jean | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 7,657 | SEC↗ |
| FOSLER GAIL D | Director | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 39,364 | SEC↗ |
| GAVIN JAMES R III | Director | M Exercise deriv | 2016-03-24 | 2016-03-28 | 5,660 | — | $0 | 0 | SEC↗ |
| STROUCKEN ALBERT P L | Director | M Exercise deriv | 2016-03-24 | 2016-03-28 | 5,660 | — | $0 | 0 | SEC↗ |
| FORSYTH JOHN D | Director | M Exercise deriv | 2016-03-24 | 2016-03-28 | 5,660 | — | $0 | 0 | SEC↗ |
| GAVIN JAMES R III | Director | M Exercise | 2016-03-24 | 2016-03-28 | 5,660 | $17.97 | $101.7K | 32,003 | SEC↗ |
| GAVIN JAMES R III | Director | S Sale | 2016-03-24 | 2016-03-28 | 5,660 | $39.97 | $226.2K | 26,343 | SEC↗ |
| STROUCKEN ALBERT P L | Director | S Sale | 2016-03-24 | 2016-03-28 | 5,660 | $39.98 | $226.3K | 20,755 | SEC↗ |
| STROUCKEN ALBERT P L | Director | M Exercise | 2016-03-24 | 2016-03-28 | 5,660 | $17.96 | $101.7K | 26,415 | SEC↗ |
| FORSYTH JOHN D | Director | S Sale | 2016-03-24 | 2016-03-28 | 5,660 | $39.97 | $226.2K | 23,324 | SEC↗ |
| FORSYTH JOHN D | Director | M Exercise | 2016-03-24 | 2016-03-28 | 5,660 | $17.97 | $101.7K | 28,984 | SEC↗ |
| BAXTER INTERNATIONAL INC | 10% Owner | J Other | 2016-03-21 | 2016-03-23 | 63,823,582 | — | $0 | 30,506,097 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | F Tax w/h | 2016-03-07 | 2016-03-08 | 267 | $39.74 | $10.6K | 67,030 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | F Tax w/h | 2016-03-07 | 2016-03-08 | 84 | $39.74 | $3.3K | 24,031 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | F Tax w/h | 2016-03-07 | 2016-03-08 | 154 | $39.74 | $6.1K | 39,435 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | F Tax w/h | 2016-03-07 | 2016-03-08 | 87 | $39.74 | $3.5K | 55,041 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | F Tax w/h | 2016-03-04 | 2016-03-07 | 109 | $39.47 | $4.3K | 55,128 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | F Tax w/h | 2016-03-04 | 2016-03-07 | 161 | $39.47 | $6.4K | 39,589 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | F Tax w/h | 2016-03-04 | 2016-03-07 | 303 | $39.47 | $12.0K | 67,297 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | F Tax w/h | 2016-03-04 | 2016-03-07 | 88 | $39.47 | $3.5K | 24,115 | SEC↗ |
| Edwards Peter G | SVP AND GENERAL COUNSEL | A Award | 2016-03-03 | 2016-03-07 | 33,062 | — | $0 | 216,311 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | F Tax w/h | 2016-03-03 | 2016-03-07 | 584 | $39.30 | $23.0K | 55,237 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2016-03-03 | 2016-03-07 | 27,976 | — | $0 | 55,821 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2016-03-03 | 2016-03-07 | 15,259 | — | $0 | 40,609 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | F Tax w/h | 2016-03-03 | 2016-03-07 | 859 | $39.30 | $33.8K | 39,750 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | F Tax w/h | 2016-03-03 | 2016-03-07 | 1,338 | $39.30 | $52.6K | 67,600 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2016-03-03 | 2016-03-07 | 35,605 | — | $0 | 68,938 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | F Tax w/h | 2016-03-03 | 2016-03-07 | 5,900 | $39.30 | $231.9K | 192,464 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award | 2016-03-03 | 2016-03-07 | 81,384 | — | $0 | 198,364 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2016-03-03 | 2016-03-07 | 10,173 | — | $0 | 24,613 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | F Tax w/h | 2016-03-03 | 2016-03-07 | 410 | $39.30 | $16.1K | 24,203 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | A Award | 2016-03-03 | 2016-03-07 | 33,062 | — | $0 | 86,310 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | F Tax w/h | 2016-03-03 | 2016-03-07 | 1,171 | $39.30 | $46.0K | 85,139 | SEC↗ |
| Meek David D. | EVP and President, Oncology | A Award | 2016-03-03 | 2016-03-07 | 27,976 | — | $0 | 52,514 | SEC↗ |
| Meek David D. | EVP and President, Oncology | F Tax w/h | 2016-03-03 | 2016-03-07 | 928 | $39.30 | $36.5K | 51,586 | SEC↗ |
| HANTSON LUDWIG | Chairman of the Board and CE | F Tax w/h | 2016-03-03 | 2016-03-07 | 6,074 | $39.30 | $238.7K | 417,881 | SEC↗ |
| HANTSON LUDWIG | Chairman of the Board and CE | A Award | 2016-03-03 | 2016-03-07 | 203,459 | — | $0 | 423,955 | SEC↗ |
| ORLOFF JOHN J | EVP and President, R&D | F Tax w/h | 2016-03-03 | 2016-03-07 | 1,408 | $39.30 | $55.3K | 96,009 | SEC↗ |
| ORLOFF JOHN J | EVP and President, R&D | A Award | 2016-03-03 | 2016-03-07 | 55,951 | — | $0 | 97,417 | SEC↗ |
| ZAGAME PATRICE | See Remarks | A Award | 2016-03-03 | 2016-03-07 | 20,346 | — | $0 | 88,829 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | F Tax w/h | 2016-03-03 | 2016-03-07 | 982 | $39.30 | $38.6K | 71,137 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | A Award | 2016-03-03 | 2016-03-07 | 15,259 | — | $0 | 72,119 | SEC↗ |
| LAW ANNE-MARIE | EVP & Head of Human Resource | F Tax w/h | 2016-03-02 | 2016-03-04 | 4,175 | $39.90 | $166.6K | 53,248 | SEC↗ |
| Devitt Blake E | Director | P Buy | 2016-02-25 | 2016-02-29 | 5,900 | $39.17 | $231.1K | 27,965 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2016-02-15 | 2016-02-17 | 182 | — | $0 | 27,847 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | F Tax w/h | 2016-02-15 | 2016-02-17 | 208 | $39.00 | $8.1K | 27,665 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2016-02-15 | 2016-02-17 | 178 | — | $0 | 27,873 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award | 2016-02-15 | 2016-02-17 | 2,886 | — | $0 | 220,498 | SEC↗ |
| HANTSON LUDWIG | President and CEO | F Tax w/h | 2016-02-15 | 2016-02-17 | 6,238 | $39.00 | $243.3K | 217,612 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award | 2016-02-15 | 2016-02-17 | 5,087 | — | $0 | 223,850 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2016-02-15 | 2016-02-17 | 151 | — | $0 | 14,440 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2016-02-15 | 2016-02-17 | 178 | — | $0 | 14,497 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | F Tax w/h | 2016-02-15 | 2016-02-17 | 208 | $39.00 | $8.1K | 14,289 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2016-02-15 | 2016-02-17 | 258 | — | $0 | 25,352 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2016-02-15 | 2016-02-17 | 305 | — | $0 | 25,447 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | F Tax w/h | 2016-02-15 | 2016-02-17 | 353 | $39.00 | $13.8K | 25,094 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2016-02-15 | 2016-02-17 | 508 | — | $0 | 33,335 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2016-02-15 | 2016-02-17 | 552 | — | $0 | 33,360 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | F Tax w/h | 2016-02-15 | 2016-02-17 | 533 | $39.00 | $20.8K | 32,827 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award | 2016-02-15 | 2016-02-17 | 4,070 | — | $0 | 118,161 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | F Tax w/h | 2016-02-15 | 2016-02-17 | 4,066 | $39.00 | $158.6K | 114,095 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award | 2016-02-15 | 2016-02-17 | 2,886 | — | $0 | 116,981 | SEC↗ |
| BAXTER INTERNATIONAL INC | 10% Owner | J Other | 2016-02-02 | 2016-02-02 | 37,573,040 | — | $0 | 94,329,679 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | F Tax w/h | 2015-12-03 | 2015-12-04 | 835 | $34.98 | $29.2K | 27,505 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | F Tax w/h | 2015-12-03 | 2015-12-04 | 1,746 | $34.98 | $61.1K | 24,975 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award deriv | 2015-12-01 | 2015-12-03 | 63,406 | — | $0 | 63,406 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | F Tax w/h | 2015-12-01 | 2015-12-03 | 6,893 | $34.63 | $238.7K | 11,610 | SEC↗ |
| ROSA-BJORKESON DAGMAR | EVP and President, Biosimila | F Tax w/h | 2015-12-01 | 2015-12-07 | 6,893 | $34.63 | $238.7K | 56,737 | SEC↗ |
| Meek David D. | EVP and President, Oncology | F Tax w/h | 2015-09-02 | 2015-09-04 | 791 | $35.03 | $27.7K | 24,277 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award | 2015-08-11 | 2015-08-13 | 999 | — | $0 | 112,556 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award | 2015-08-11 | 2015-08-13 | 895 | — | $0 | 113,451 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award | 2015-08-11 | 2015-08-13 | 1,249 | — | $0 | 216,326 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award | 2015-08-11 | 2015-08-13 | 895 | — | $0 | 217,221 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2015-08-11 | 2015-08-13 | 44 | — | $0 | 27,921 | SEC↗ |
| LEONARDI JACOPO | EVP and President, Immunolog | A Award | 2015-08-11 | 2015-08-13 | 56 | — | $0 | 27,977 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2015-08-11 | 2015-08-13 | 80 | — | $0 | 26,361 | SEC↗ |
| GLASSPOOL JOHN | See Remarks | A Award | 2015-08-11 | 2015-08-13 | 75 | — | $0 | 26,281 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2015-08-11 | 2015-08-13 | 157 | — | $0 | 32,600 | SEC↗ |
| Goff Brian | EVP and President, Hematolog | A Award | 2015-08-11 | 2015-08-13 | 135 | — | $0 | 32,443 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2015-08-11 | 2015-08-13 | 47 | — | $0 | 14,248 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award | 2015-08-11 | 2015-08-13 | 44 | — | $0 | 14,201 | SEC↗ |
| Nader Francois | Director | A Award deriv | 2015-07-27 | 2015-07-29 | 5,960 | — | $0 | 5,960 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2015-07-27 | 2015-07-29 | 5,960 | — | $0 | 5,960 | SEC↗ |
| Nader Francois | Director | A Award | 2015-07-27 | 2015-07-29 | 3,140 | — | $0 | 3,140 | SEC↗ |
| Ferrante Karen Jean | Director | A Award | 2015-07-27 | 2015-07-29 | 3,140 | — | $0 | 3,140 | SEC↗ |
| FOSLER GAIL D | Director | A Award deriv | 2015-07-01 | 2015-07-06 | 293 | — | $0 | 293 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 12,588 | — | $0 | 12,588 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,110 | — | $0 | 4,110 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,930 | — | $0 | 3,930 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,020 | — | $0 | 4,020 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,990 | — | $0 | 4,990 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,760 | — | $0 | 3,760 | SEC↗ |
| FOSLER GAIL D | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,280 | — | $0 | 4,280 | SEC↗ |
| Edwards Peter G | EVP and General Counsel | A Award deriv | 2015-07-01 | 2015-07-06 | 76,202 | — | $0 | 76,202 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,990 | — | $0 | 4,990 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,660 | — | $0 | 5,660 | SEC↗ |
| GAVIN JAMES R III | Director | A Award deriv | 2015-07-01 | 2015-07-06 | 3,810 | — | $0 | 3,810 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,110 | — | $0 | 4,110 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,930 | — | $0 | 3,930 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,020 | — | $0 | 4,020 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,320 | — | $0 | 4,320 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,680 | — | $0 | 5,680 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,760 | — | $0 | 3,760 | SEC↗ |
| GAVIN JAMES R III | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,280 | — | $0 | 4,280 | SEC↗ |
| HANTSON LUDWIG | President and CEO | J Other deriv | 2015-07-01 | 2015-07-06 | 118,953 | — | $0 | 118,953 | SEC↗ |
| HANTSON LUDWIG | President and CEO | J Other deriv | 2015-07-01 | 2015-07-06 | 287,936 | — | $0 | 287,936 | SEC↗ |
| HANTSON LUDWIG | President and CEO | J Other deriv | 2015-07-01 | 2015-07-06 | 103,181 | — | $0 | 103,181 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award deriv | 2015-07-01 | 2015-07-06 | 507,380 | — | $0 | 507,380 | SEC↗ |
| HANTSON LUDWIG | President and CEO | J Other deriv | 2015-07-01 | 2015-07-06 | 88,597 | — | $0 | 88,597 | SEC↗ |
| HANTSON LUDWIG | President and CEO | J Other deriv | 2015-07-01 | 2015-07-06 | 84,367 | — | $0 | 84,367 | SEC↗ |
| HANTSON LUDWIG | President and CEO | A Award deriv | 2015-07-01 | 2015-07-06 | 328,253 | — | $0 | 328,253 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,680 | — | $0 | 5,680 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,760 | — | $0 | 3,760 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,280 | — | $0 | 4,280 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,320 | — | $0 | 4,320 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,990 | — | $0 | 4,990 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,020 | — | $0 | 4,020 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,930 | — | $0 | 3,930 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,110 | — | $0 | 4,110 | SEC↗ |
| STROUCKEN ALBERT P L | Director | A Award deriv | 2015-07-01 | 2015-07-06 | 3,810 | — | $0 | 3,810 | SEC↗ |
| STROUCKEN ALBERT P L | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,660 | — | $0 | 5,660 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,930 | — | $0 | 3,930 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,680 | — | $0 | 5,680 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,320 | — | $0 | 4,320 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,990 | — | $0 | 4,990 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,020 | — | $0 | 4,020 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,760 | — | $0 | 3,760 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,110 | — | $0 | 4,110 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 12,588 | — | $0 | 12,588 | SEC↗ |
| HOCKMEYER WAYNE T | Director | A Award deriv | 2015-07-01 | 2015-07-06 | 293 | — | $0 | 293 | SEC↗ |
| HOCKMEYER WAYNE T | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 2,500 | — | $0 | 2,500 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | J Other deriv | 2015-07-01 | 2015-07-06 | 1,887 | — | $0 | 1,887 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | A Award deriv | 2015-07-01 | 2015-07-06 | 11,137 | — | $0 | 11,137 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | J Other deriv | 2015-07-01 | 2015-07-06 | 8,327 | — | $0 | 8,327 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | J Other deriv | 2015-07-01 | 2015-07-06 | 9,292 | — | $0 | 9,292 | SEC↗ |
| MCCOY JOHN A. | SVP and Controller | J Other deriv | 2015-07-01 | 2015-07-06 | 25,459 | — | $0 | 25,459 | SEC↗ |
| Meek David D. | EVP and President, Oncology | J Other deriv | 2015-07-01 | 2015-07-06 | 43,334 | — | $0 | 43,334 | SEC↗ |
| Meek David D. | EVP and President, Oncology | J Other deriv | 2015-07-01 | 2015-07-06 | 54,553 | — | $0 | 54,553 | SEC↗ |
| Meek David D. | EVP and President, Oncology | A Award deriv | 2015-07-01 | 2015-07-06 | 191,421 | — | $0 | 191,421 | SEC↗ |
| Meek David D. | EVP and President, Oncology | A Award deriv | 2015-07-01 | 2015-07-06 | 6,155 | — | $0 | 6,155 | SEC↗ |
| Devitt Blake E | Director | A Award deriv | 2015-07-01 | 2015-07-06 | 293 | — | $0 | 293 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 12,588 | — | $0 | 12,588 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,110 | — | $0 | 4,110 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,930 | — | $0 | 3,930 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,020 | — | $0 | 4,020 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,990 | — | $0 | 4,990 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,320 | — | $0 | 4,320 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 5,680 | — | $0 | 5,680 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 3,760 | — | $0 | 3,760 | SEC↗ |
| Devitt Blake E | Director | J Other deriv | 2015-07-01 | 2015-07-06 | 4,280 | — | $0 | 4,280 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | J Other deriv | 2015-07-01 | 2015-07-06 | 103,181 | — | $0 | 103,181 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award deriv | 2015-07-01 | 2015-07-06 | 380,535 | — | $0 | 380,535 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | J Other deriv | 2015-07-01 | 2015-07-06 | 287,936 | — | $0 | 287,936 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | A Award deriv | 2015-07-01 | 2015-07-06 | 35,170 | — | $0 | 35,170 | SEC↗ |
| HOMBACH ROBERT J. | EVP, CFO and COO | J Other deriv | 2015-07-01 | 2015-07-06 | 95,163 | — | $0 | 95,163 | SEC↗ |